e-NOBORI Observational Registry of Nobori DES (e-NOBORI)
Prospective, Single-Arm, Multi-Centre, Observational Registry to Further Validate Safety and Efficacy of the Nobori DES in Real-World Patients
Sponsor: Terumo Europe N.V.
A observational or N/A phase clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Terumo Europe N.V. and has accumulated 10 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Completed
-
Sep 2025 — Dec 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 5 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Aug 2018 — Nov 2019 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Terumo Europe N.V.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Al Mansurah, Egypt , Albacete, Spain , Alexandria, Egypt , Alicante, Spain , Almería, Spain , Amiens, France , Angers, France , Antony, France , Aubervilliers, France and 188 more locations